Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism

Journal of Endocrinological Investigation

Volumn 23, Issue 1, 2000, Pages 31-36

  Sohmiya, Motoi ^a   Kato, Y ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Anemia; Erythropoietin; Insulin like growth factor I; Panhypopituitarism; Recombinant human growth hormone

Indexed keywords

ARGININE; DESMOPRESSIN; ERYTHROPOIETIN; GONADORELIN; HEMOGLOBIN; HYDROCORTISONE; INSULIN; LEVOTHYROXINE SODIUM; PROTIRELIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ANEMIA; ARTICLE; CASE REPORT; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LONG TERM CARE; SUBSTITUTION THERAPY;

EID: 0033963707     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343673     Document Type: Article

References (32)

1. Clemons G.K., Fitzsimmons S.L., DeManincor D. Immunoreactive erythropoietin concentration in fetal and neonatal rats and the effects of hypoxia. Blood 1986, 68: 892-899.
2. Kurtz A., Eckardt K.U., Neumann R., Kaissling B., Le Hir M., Bauer C. Site of erythropoietin formation. Contrib. Nephrol. 1989, 76: 14-23.
3. Nagy E., Berczi I. Pituitary dependence of bone marrow function. Br. J. Haematol. 1989, 71: 457-462.
4. Peschle C., Rappaport I.A., Magli M.C., Marone G., Lettieri F., Cillo C., Gordon A.S. Role of the hypophysis in erythropoietin production during hypoxia. Blood 1978, 51: 1117-1124.
5. Fandrey J., Pagel H., Frede S., Wolff M., Jelkmann W. Thyroid hormones enhance hypoxia-induced erythropoietin production in vitro. Exp. Hematol. 1994, 22: 272-277.
6. Brenner B., Fandrey J., Jelkmann W. Serum immunoreactive erythropoietin in hyper- and hypothyroidism: clinical observations related to cell culture studies. Eur. J. Haematol. 1994, 53: 6-10.
7. Sohmiya M., Ishikawa K., Kato Y. Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failure. Eur. J. Endocrinol. 1998, 138: 302-306.
8. Hashida S., Ishikawa E., Nakagawa K., Ohtaki S., Ichioka T., Nakajima K. Demonstration of human growth hormone in normal urine by a highly specific and sensitive enzyme immunoassay. Anal. Lett. 1985, 18: 1623-1634.
9. Sohmiya M., Kato Y. Renal clearance, metabolic clearance rate, and half-life of human growth hormone in young and aged subjects. J. Clin. Endocrinol. Metab. 1992, 75: 1487-1490.
10. Sohmiya M., Yamamoto H., Kato Y. Age- and sex-related changes in urinary growth hormone (GH) levels in normal adults. Biomed. Res. 1993, 4: 227-238.
11. Kato Y., Takagi C., Tanaka J., Masaki Y., Furuya H. Effect of daily subcutaneous administration of recombinant erythropoietin on chronic anemia in rheumatoid arthritis. Intern. Med. 1994, 33: 193-197.
12. Yamamoto H., Sohmiya M., Oka N., Kato Y. Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol. (Copenh.) 1991, 124: 497-500.
13. Ishikawa K., Sohmiya M., Furuya H., Kato Y. A case of Sheehan's syndrome associated with severe anemia and empty sella proved 48 years after postpartum hemorrhage. Endocrine J. 1995, 42: 803-809.
14. Golde D.W., Bersch N, Li C.H. Growth hormone: species-specific stimulation of erythropoiesis in vitro. Science 1977, 196: 1112-1113.
15. Meineke H.A., Crafts R.C. Further observations on the mechanism by which androgens and growth hormone influence erythropoiesis. Ann. NY Acad. Sci. 1968, 149: 298-307.
16. Fisher J.W., Roh B.L., Couch C., Nightingale W.O. Influence of cobalt, sheep erythropoietin and several hormones on erythropoiesis in bone marrows of isolated perfused hind limbs of dogs. Blood 1964, 23: 87-98.
17. Kotzmann H., Riedl M., Clodi M., Barnas U., Kaider A, Hocker P., Luger A. The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur. J. Clin. Invest. 1996, 26: 1175-1181.
18. Jepson J.H., McGarry E.E. Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone. Blood 1972, 39: 238-248.
19. Ten Have S.M.T.H., van der Lely A.J., Lamberts S.W.J. Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy. Clin. Endocrinol. (Ofx.) 1997, 47: 565-570.
20. Koury S.T., Bondurant M.C., Koury M.J. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988, 71: 524-527.
21. Koury S.T., Koury M.J., Bondurant M.C., Caro J., Graber S.E. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989, 74: 645-651.
22. Eckardt K., Kurtz A., Scholz H., Bauer C. Regulation of erythropoietin formation in vivo. Contrib. Nephrol. 1989, 76: 33-38.
23. Jepson J.H., McGarry E.E., Lowenstein L.L. Erythropoietin excretion in a hypopituitary patient. Effects of testosterone and vasopressin. Arch. Intern. Med. 1968, 122: 265-270.
24. Claustres M., Chatelain P., Sultan C. Insulin-like growth factor I stimulates human erythroid colony formation in vitro. J. Clin. Endocrinol. Metabol. 1987, 65: 78-82.
25. Kurtz A., Zapf J., Eckardt K.U., Clemons G., Froesch E.R., Bauer C. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc. Natl. Acad. Sci. USA 1988, 85: 7825-7829.
26. Quin J.D., Miell J.P., Smith K., Gordon D., Strachan J., Dick J.B., MacCuish A.C. Effect of insulin-like growth factor-I therapy on erythropoietin concentrations in extreme insulin resistance. Diabetologia 1994, 37: 439.
27. Watkinson G., McMenemey W.H., Evans G. Hypopituitarism, hypogonadism, and anemia treated with testosterone. Lancet 1947, 252: 631-634.
28. Alexanian R. Erythropoietin and erythropoiesis in anemic man following androgen. Blood 1969, 33: 564-572.
29. Malgor L.A., Fisher J.W. Effects of testosterone on erythropoietin production in isolated perfused kidneys. Am. J. Physiol. 1970, 218: 1732-1736.
30. Sohmiya M., Kakiba T., Kato Y. Therapeutic use of continuous subcutaneous infusion of human erythropoietin in malnourished predialysis anemic patients with diabetic nephropathy. Eur. J. Endocrinol. 1998, 139: 367-370.
31. Pavlovic-Kentera V., Clemons G.K., Biljanovic-Paunovic L., Marisavljevic D., Lezaic V., Pokrajac M., Djukanovic L. Serum erythropoietin levels in hemodialysed patients after administration of recombinant human erythropoietin. Biomed. Pharmacother. 1992, 46: 37-43.
32. Laursen T., Jorgensen J.O., Jakobsen G., Hansen B.L., Christiansen J.S. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH deficient patients. J. Clin. Endocrinol. Metab. 1995, 80: 2410-2418.